These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7830247)

  • 1. Significance of viable skin layers in percutaneous permeation and its implication in mathematical models: theoretical consideration based on parameters for betamethasone 17-valerate.
    Kubota K; Maibach HI
    J Pharm Sci; 1994 Sep; 83(9):1300-6. PubMed ID: 7830247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous absorption: a single-layer model.
    Kubota K; Sznitowska M; Maibach HI
    J Pharm Sci; 1993 May; 82(5):450-6. PubMed ID: 8360820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro percutaneous permeation of betamethasone and betamethasone 17-valerate.
    Kubota K; Maibach HI
    J Pharm Sci; 1993 Oct; 82(10):1039-45. PubMed ID: 8254489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption.
    George K
    Biomed Eng Online; 2005 Jul; 4():40. PubMed ID: 15992411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous diffusion and metabolism of betamethasone 17-valerate in the living skin equivalent.
    Kubota K; Ademola J; Maibach HI
    J Pharm Sci; 1995 Dec; 84(12):1478-81. PubMed ID: 8748331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous permeation of betamethasone 17-valerate incorporated in lipid nanoparticles.
    Zhang J; Smith E
    J Pharm Sci; 2011 Mar; 100(3):896-903. PubMed ID: 20839362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion modeling of percutaneous absorption kinetics. 1. Effects of flow rate, receptor sampling rate, and viable epidermal resistance for a constant donor concentration.
    Anissimov YG; Roberts MS
    J Pharm Sci; 1999 Nov; 88(11):1201-9. PubMed ID: 10564070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of simultaneous transport and metabolism of ethyl nicotinate in hairless rat skin.
    Sugibayashi K; Hayashi T; Hatanaka T; Ogihara M; Morimoto Y
    Pharm Res; 1996 Jun; 13(6):855-60. PubMed ID: 8792422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo percutaneous absorption: a key role for stratum corneum/vehicle partitioning.
    Rougier A; Rallis M; Krien P; Lotte C
    Arch Dermatol Res; 1990; 282(8):498-505. PubMed ID: 2128017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of PLGA and lecithin/chitosan nanoparticles for dermal targeting of betamethasone valerate.
    Özcan I; Azizoğlu E; Senyiğit T; Özyazici M; Özer Ö
    J Drug Target; 2013 Jul; 21(6):542-50. PubMed ID: 23390922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of enzyme distribution and diffusion on permeation profile of prodrug through viable skin: theoretical aspects for several steady-state fluxes in two transport directions.
    Hatanaka T; Rittirod T; Katayama K; Koizumi T
    Biol Pharm Bull; 1999 Jun; 22(6):623-6. PubMed ID: 10408238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A compartment model for percutaneous absorption: compatibility of lag time and steady-state flux with diffusion model.
    Kubota K; Maibach HI
    J Pharm Sci; 1992 Sep; 81(9):863-5. PubMed ID: 1432629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between in vivo skin blanching and in vitro release rate for betamethasone valerate creams.
    Shah VP; Elkins J; Skelly JP
    J Pharm Sci; 1992 Jan; 81(1):104-6. PubMed ID: 1619561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of drug penetration through the skin by the two-layer skin model.
    Okamoto H; Yamashita F; Saito K; Hashida M
    Pharm Res; 1989 Nov; 6(11):931-7. PubMed ID: 2594684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of dermal bioavailability: predicting the input function for topical glucocorticoids using stratum corneum sampling.
    Pensado A; McGrogan A; White KAJ; Bunge AL; Guy RH; Delgado-Charro MB
    Drug Deliv Transl Res; 2022 Apr; 12(4):851-861. PubMed ID: 34599470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A physiologically based mathematical model of dermal absorption in man.
    Auton TR; Westhead DR; Woollen BH; Scott RC; Wilks MF
    Hum Exp Toxicol; 1994 Jan; 13(1):51-60. PubMed ID: 8198830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro percutaneous absorption of fusidic acid and betamethasone 17-valerate across canine skin.
    Degim IT; Hadgraft J; Houghton E; Teale P
    J Small Anim Pract; 1999 Nov; 40(11):515-8. PubMed ID: 10649594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioequivalence Methodologies for Topical Drug Products: In Vitro and Ex Vivo Studies with a Corticosteroid and an Anti-Fungal Drug.
    Leal LB; Cordery SF; Delgado-Charro MB; Bunge AL; Guy RH
    Pharm Res; 2017 Apr; 34(4):730-737. PubMed ID: 28097506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous absorption of steroids: relative contributions of epidermal penetration and dermal clearance.
    Siddiqui O; Roberts MS; Polack AE
    J Pharmacokinet Biopharm; 1989 Aug; 17(4):405-24. PubMed ID: 2614679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous absorption of benzoic acid across human skin. I. In vitro experiments and mathematical modeling.
    Parry GE; Bunge AL; Silcox GD; Pershing LK; Pershing DW
    Pharm Res; 1990 Mar; 7(3):230-6. PubMed ID: 2339094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.